Loading clinical trials...
Loading clinical trials...
Rationale: This project elaborates on a novel finding of the investigators that has not yet been reported in literature, namely the presence of elevated levels of atypical B cells in participants with...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Amsterdam UMC, location VUmc
NCT06954636 · Glioblastoma Multiforme, Adult, Glioblastoma or Gliosarcoma, and more
NCT03213002 · Glioblastoma Multiforme (GBM), Glioblastoma, and more
NCT02974738 · Advanced Solid Tumors, Solid Tumor, and more
NCT03522298 · Glioblastoma, Adult
NCT06845020 · Glioblastoma, Glioblastoma WHO Grade IV, and more
Amsterdam Medical Universities
Amsterdam, North Holland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions